Projected Income Statement: Exelixis, Inc.

Forecast Balance Sheet: Exelixis, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -1,467 -1,308 -995 -1,111 -1,059 -774 -1,716 -2,971
Change - 10.84% 23.93% -11.66% 4.68% 26.92% -121.71% -73.14%
Announcement Date 2/17/22 2/7/23 2/6/24 2/11/25 2/10/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Exelixis, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 64.22 138.5 40.47 28.44 8.429 41.96 48.16 53.24
Change - 115.58% -70.77% -29.74% -70.36% 397.85% 14.76% 10.55%
Free Cash Flow (FCF) 1 336.6 224.2 292.9 671.5 875.8 790.4 932.7 1,450
Change - -33.4% 30.65% 129.31% 30.42% -9.76% 18% 55.48%
Announcement Date 2/17/22 2/7/23 2/6/24 2/11/25 2/10/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Exelixis, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 20.93% 13.8% 10.74% 29.21% 38.84% 42.83% 42.25% 48.9%
EBIT Margin (%) 19.98% 12.51% 9.34% 27.88% 37.59% 39% 40.76% 43.7%
EBT Margin (%) 20.5% 14.55% 14.07% 31.43% 40.57% 40.94% 42.78% 46.16%
Net margin (%) 16.1% 11.31% 11.35% 24.04% 33.73% 31.49% 32.27% 34.7%
FCF margin (%) 23.46% 13.91% 16% 30.96% 37.75% 30.4% 31.82% 44.7%
FCF / Net Income (%) 145.67% 122.97% 140.95% 128.83% 111.92% 96.55% 98.61% 128.81%

Profitability

        
ROA 9.72% 6.41% 6.91% 17.7% 27.02% 25.4% 24.8% 23.5%
ROE 11.3% 7.76% 8.74% 23.13% 35.53% 30.64% 27.78% 26.65%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 4.48% 8.59% 2.21% 1.31% 0.36% 1.61% 1.64% 1.64%
CAPEX / EBITDA (%) 21.39% 62.27% 20.58% 4.49% 0.94% 3.77% 3.89% 3.36%
CAPEX / FCF (%) 19.08% 61.77% 13.82% 4.23% 0.96% 5.31% 5.16% 3.67%

Items per share

        
Cash flow per share 1 1.243 1.117 1.037 2.364 3.137 3.357 3.864 5.15
Change - -10.14% -7.19% 127.96% 32.72% 7.01% 15.12% 33.26%
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 6.933 7.681 7.477 7.966 8.234 11.2 15.03 20.02
Change - 10.79% -2.66% 6.54% 3.37% 36.02% 34.21% 33.17%
EPS 1 0.72 0.56 0.65 1.76 2.78 3.179 3.728 4.595
Change - -22.22% 16.07% 170.77% 57.95% 14.35% 17.28% 23.24%
Nbr of stocks (in thousands) 316,397 322,561 310,974 285,579 269,203 251,355 251,355 251,355
Announcement Date 2/17/22 2/7/23 2/6/24 2/11/25 2/10/26 - - -
1USD
Estimates
2026 *2027 *
P/E 17.7x 15x
PBR 5.01x 3.73x
EV / Sales 5.13x 4.23x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
56.11USD
Average target price
50.38USD
Spread / Average Target
-10.22%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EXEL Stock
  4. Financials Exelixis, Inc.